Standard absorbed-dose distributions are measured in an homogeneous cubical phantom as described in Section 3.1.1. These are assumed to represent the absorbed-dose distributions which would be found in a patient if the body was composed uniformly of standard phantom material. However, the body of the patient is neither homogeneous nor a cube and the tissues and organs may differ in composition and density from those of the homogeneous phantom.
Regions of different composition or density will produce deviations from the standard distribution which vary widely depending upon the amount and type of the nonstandard material present and the neutron energy. The effects arise from changes in the relative importance of the various nuclear processes by which neutrons interact with the constituent elements of tissue and the spatial frequency with which these occur. These lead to variations in the kerma per unit fluence and to alterations in the attenuation of the primary beam, the energy spectrum and fluence of scattered neutrons, and the energy spectrum and fluence of the gamma rays resulting from the neutron interactions.
Alterations to the kerma affect the absorbed dose within or very close to the nonstandard region. For example, the reduced kerma in bone will result in a reduction in the absorbed dose received by soft tissues within the bone and immediately adjacent to it. An alteration in the attenuation of the primary neutron beam affects the absorbed dose at points which lie beyond the nonstandard region while an alteration in the pattern of scattered neutrons and in the fluence of gamma rays affects primarily the absorbed dose at points which are relatively close to the nonstandard region but which need not necessarily be directly behind it.
For the determination of the standard absorbeddose distributions, the phantom is positioned such that the central axis of the radiation beam is normal to the surface of the phantom. During treatment, however, the beam is directed through a body surface which may be at an angle differing appreciably from a right angle and the surface may be curved in a complex way. Two consequences arise from this: positions below the body surface have altered thicknesses of absorbing material between them and the source and they may be near to different volumes of scattering material. Consequently, both the primary and scattered components of the absorbed dose may be altered as compared to a rectangular phantom. Situations can also 52 exist in which only the scattered component differs. First, when the radiation passes through sections of the body having thicknesses less than that of the standard phantom, the absorbed dose near the exit surface will be smaller than that predicted from the standard curves due to the absence of backscattering material. Second, during the treatment of irregularly shaped sections of the human body scattering material may be absent from regions adjacent to or within the irradiated volume.
Effects of Variation in Atomic
Composition on Kerma
The principal constituent elements of all tissues are hydrogen, carbon, nitrogen, and oxygen. Bone also contains significant quantities of phosphorus and calcium. Other elements, primarily sodium, magnesium, sulfur, chlorine, and potassium, are present in small quantities (usually less than a total of 1 to 2% by weight), and are of minor significance for neutron dosimetry.
There are significant differences between the atomic compositions of various human tissues (Table 5 .1) as discussed for instance in ICRP Publication 23 (ICRP, 1975) and more recently in ICRU Report 44 (ICRU, 1989) . Generally, for biological and medical applications of fast neutrons, energy deposition is quoted in a reference tissue having an atomic composition based on that of striated muscle (ICRU muscle; ICRU, 1964) (see Section 3.1.1). The relative contributions to the kerma in this tissue due to each of the constituent elements depend upon neutron energy ( Figure 5 .1).
Up to a neutron energy of about 8 MeV, recoil protons resulting from elastic scattering with hydrogen contribute more than 85% of the total kerma. As the neutron energy increases, this contribution falls to about 70% at an energy of 14 MeV and to about 55% at an energy of 50 MeV. Due to the large contribution to the kerma from these recoil protons, energy deposition in various tissues is determined primarily by their hydrogen content and the kerma in one tissue can be estimated approximately from that in another tissue by applying a correction based only on the relative hydrogen content. However, where greater accuracy is required, derivation of the correction factor must be based on the relative abundance of all elements, a knowledge of the neutron energy spectrum at the point of interest, and kerma factors for each element. For a given element, the kerma factor is the product of the mass energy transfer coefficient, µu/ p, and the neutron energy, Em (ICRU, 1977) . Kerma in any given tissue relative to that in the reference tissue (the 5. 1 Distribution Corrections • • • 5 3 (ICRP, 1975) except muscle [ICRU Report No. lOb (ICRU, 1964) ; also cited in ICRU Report 26 ( ICR U, 1977) ] and cortical bone (White and Constantinou, 1982) . Later data are given in the ICRU Report on tissue substitutes (ICRU, 1989 ). kerma ratio, Km!Kt) can be calculated from the equation:
where Km and Kt are the kerma values in the tissue under consideration (material m) and the reference tissue, respectively, and mWL and tWL are the proportions by weight of element L in the tissue under consideration and the reference tissue, respectively, <f>En is the differential fluence of neutrons at energy En and {µu/ p)~n is the kerma factor for element L at energy En.
Kerma ratios, Km!Kt, for the tissues and tissue substitutes listed in Table 5 .1 are given in Table 5 .2 (Awschalom et al., 1983b) . The uncertainties given in Table  5 .2 are derived from uncertainties in the energy spectra of the neutron beams, variations in the elemental composition of the tissues and uncertainties in the published kerma values, particularly for neutrons with energies greater than 20 MeV.
In a scattering medium, the neutron energy spectrum differs from that in air due to scattering and filtration but since the kerma ratios vary only slowly with neutron energy, the data of , 1978; Schmidt et al., 1980; Mijnheer et al., 1981a; Bonnett and Parnell, 1982) . In addition, Awschalom et al. (1983b) concluded that uncertainties in the neutron spectra at low energies did not influence the average kerma-factor ratios significantly. Compared with the reference tissue, the energy dissipated in bone is reduced whereas with fatty tissue there is greater energy dissipation, a situation which is the converse of that occurring with photons. In brain tissue, some additional energy is dissipated because of the concentration of lipid but since water is less abundant in brain tissue than in the reference tissue, the net effect is only a moderate increase in kerma. For tumor tissues, where the atomic composition is usually unknown, the kerma ratio is assumed to be unity.
In practice, the difference in kerma between various tissues is usually not taken into consideration and, unless contrary indications are given, it is assumed that the absorbed dose quoted is the absorbed dose in the reference material located at the point of interest.
Interface Effects
Kerma and absorbed dose are practically equal under conditions of secondary charged-particle equilibrium. Thus, providing that secondary charged-particle equilibrium exists, the ratio of absorbed doses to two tissues or organs will be identical to the ratio of the kermas in those tissues or organs. Secondary chargedparticle equilibrium might not exist close to the boundary of an organ or tissue and the above relation-ship between absorbed dose and kerma might not apply. (See also ICRU Report 13, ICRU, 1969) .
For all neutron energies considered in this Report, the absorbed dose is deposited primarily by protons, alpha particles, and recoil nuclei of carbon, nitrogen, and oxygen. For any given neutron energy, the maximum range of the recoil protons is about 20 times that of the alpha particles and 200 times that of the heavy recoils (ICRU, 1977) . In addition, these are liberated primarily in the forward direction relative to the incident neutrons. Thus, the absorbed dose on the distal side of an interface between two dissimilar tissues irradiated with a beam of fast neutrons will depend upon the kerma in both tissues and the distance from the interface. This perturbation of the absorbed dose will extend over a distance corresponding to the range of a proton which has the same energy as the maximum energy of the neutrons in the beam.
On the proximal side of the interface, the principal charged particles traveling contrary to the direction of the incident neutron beam are some alpha particles produced by interactions between neutrons from the incident beam and carbon or oxygen nuclei and protons, alpha particles and heavy recoil nuclei resulting from the interactions of back-scattered neutrons. These back-scattered neutrons have a maximum energy which is considerably lower than that of those traveling in the direction of the primary beam and, at any point, contribute only a few percent to the kerma at that point. Thus, the perturbation of the absorbed dose on the proximal side of the interface will be smaller than that on the distal side and will extend over a shorter distance.
The principal interface of concern in neutron therapy is that between air and the skin of the patient on which the neutron beam is incident. The variation of absorbed dose close to the surface of an homogeneous phantom has been discussed in Section 4.3. However, the superficial layers of the human body, consisting of epidermis, dermis, adipose, and muscle, are not homogeneous. Calculations of the absorbed doses due to protons liberated by 14-MeV neutrons within such a configuration are shown in Figure 5 . 2 (Pfister et al., 1981b) . These calculations show clearly the build-up of absorbed dose to the epidermis and dermis, the increased absorbed dose to adipose tissue relative to muscle and the perturbation of the absorbed dose to the distal side of dermis/adipose tissue and adipose tissue/muscle interfaces.
Pfister et al. (1981b) made similar calculations for variations of absorbed dose across a bone/tissue interface. An example of these calculations for rib and lung is shown in Figure 5 .3. The changes in absorbed dose at the boundary between the media is caused by influences of the kerma of the neutrons in the different media as well as variations in stopping power of the protons in these media. On the distal side of the bone, there exists a transitional zone in which the equilibrium fluence of secondary charged particles is re-established. Consequently, cells very close to the surface of bone, or cells in small cavities within bone are protected to some extent. This is beneficial where the cells are normal but detrimental when malignant cells lie close to bone.
Effects of Body Inhomogeneities on
Absorbed-Dose Distributions
Regions of the body with atomic compositions (particularly the hydrogen content) and densities that differ significantly from those of reference tissue are air cavities, lung, bone, fat, and brain. The effect of 
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differences in atomic composition on the kerma within a particular organ or tissue has been discussed in Section 5.1.2 while the absorbed dose close to the interface between two dissimilar tissues has been discussed in Section 5.1.3. This section summarizes the experimental and theoretical investigations into the modifications to the basic absorbed-dose data at points within or remote from an inhomogeneity. These alterations in the absorbed-dose distribution in an homogeneous phantom are a result of changes in the attenuation of the primary neutron beam or the energy spectrum and fluence of scattered neutrons resulting from the presence of the inhomogeneity. Section 5.2.3 discusses the computational methods whereby these changes can be incorporated into routine treatment planning.
Air Cavities. The main air cavities in the body are the bronchus, larynx, pharynx, and maxillary sinus. The sizes of the larynx and pharynx do not vary significantly among healthy people, but these and some other cavities may change due to the tumor itself. Gases may also be present in the bowels, but the position and size of these inhomogeneities vary from hour to hour.
Little experimental information exists regarding the correction to be made to the absorbed dose behind an air-filled cavity. Figure 5 .4 shows the results of some measurements of the neutron component of the absorbed dose behind a 4-cm diameter cylindrical airfilled cavity, located with its center at 7.5-cm deep on the beam axis, in a water phantom irradiated with neutrons produced by the d(16) + Be(8) interaction (Blake, 1982) . These investigations showed that the displacement of the depth-dose curve on the beam axis decreased: (i) as the diameter of the cavity was decreased, (ii) as the distance behind the cavity was 5POl«ilOSA increased, and (iii) as the field size was increased. For example, the displacement varied between 0.75 times the diameter of the cavity at a distance of 2 cm behind a 4-cm diameter cavity using a 5 cm X 5-cm field to 0.45 times the diameter of the cavity at a distance of 20 cm behind a 1-cm diameter cavity using a 20 cm X 20-3 I~ ~o cm field. There was no significant dependence of this displacement upon the depth in the phantom of the cavity. For cobalt-60 gamma rays and 4-MV x rays, a shift of the isodose curves of 0.6 times the thickness of the air cavity is recommended together with an indication that this factor would be lower at higher energies (ICRU, 1976) . The penetrations of the fast neutron beams produced by the d + T interaction and by the d(l6) + Be(8) interaction are smaller than that of cobalt-60 gamma rays (see Table 4 .4). Thus, in the absence of further experimental information for fast neutrons, data obtained with photons having comparable penetration into tissue to that of the neutron beam could be used.
Lung. The density of this organ can range from 0.26 g cm-a to just over 1.0 g cm-3 depending upon the amount of air filling it (ICRP, 1975) . It can also vary widely if a tumor is present. Normally, in the absence of specific information about the average density of a particular lung, a value of 0.3 g cm-3 is assumed. The hydrogen content of lung tissue is only marginally lower than that of muscle tissue (Table 5 .1) and the kerma in lung is, therefore, only about 1 % less than in muscle tissue.
McGinley ( Depth in water phantom I cm mersed in a thoracic phantom irradiated with neutrons produced by the d + T interaction. Immediately in front of the lung, the neutron and photon absorbed doses are reduced in comparison with measurements in the homogeneous phantom as a result of reduced scattering in the lung. Within the lung the total absorbed dose was less on the proximal side and greater on the distal side compared with that in the homogeneous phantom ( Figure 5 .5).
Measurements of the effect of lung on the absorbeddose distributions in an homogeneous phantom for cyclotron-produced fast neutron beams have been reported by McGinley and McLaren (1974) ; Smith et al. (1976) ; Wootton et al. (1977); and Constantinou (1978) . McGinley and McLaren (1974) , using fast neutrons produced by the d(35) + Be reaction, measured the dose in lung located in the same thoracic phantom as that used by McGinley (1973) with neutrons produced 5. 1 Distribution Corrections • • • 5 7 by the d + T interaction. For depths less than 9 cm in lung, the total absorbed dose was less than that measured in an homogeneous phantom, while at greater depths (up to a maximum lung thickness of 17 cm), an increased total absorbed dose was found, with correction factors of 1.11 at 12-cm deep and 1.28 at 16-cm deep. Smith et al. (1976) examined the dose perturbation in the lung using neutrons produced by the d(50) + Be interaction. Silicon diode dosimeters were inserted into the esophagus and bronchi of anesthetized rhesus monkeys. The measured neutron doses, Dm, were compared with the doses, Dp, predicted by standard isodose distributions. The measured doses exceeded the predicted doses in all cases and the correction factor, Dm/Dp, increased with increasing thickness, dL, oflung and was also found to depend upon the thickness, dt, of tissue overlying the lung. An analysis of the data gave the relationship: (1977) also found that the absorbed dose behind a lung substitute material (fiberboard) immersed in a soft tissue substitute phantom was higher than that measured in the absence of the inhomogeneity. The correction factors ( Figure 5 .6) increased with both distance from the inhomogeneity and with thickness of lung traversed but were independent of the amount of normal tissue overlying the inhomogeneity. With this beam, the correction factors were smaller than those measured by Constantinou (1978) for neutrons produced by the d(16) + Be (8) interaction.
Constantinou (1978) measured the neutron and photon absorbed doses on the beam axis of a fast neutron beam produced by the d(16) + Be(8) interaction in front of, within, and behind various thicknesses oflung substitute material located at various depths in a tissue-substitute phantom ( Figure 5 .7). The variation of neutron absorbed dose in the lung showed a similar pattern to that observed with d + T neutrons being lower at the proximal side and higher at the distal side of the lung relative to those in an homoge- neous medium. At points in front of, and within the lung, the effect of field size on the correction factors was small. Behind the lung, the correction factors increase with thickness of lung traversed, with distance behind the lung and with decreasing field size. Under some circumstances, the neutron absorbed dose could be as much as 100% larger than the absorbed dose that standard depth-dose curves would indicate.
Although lung correction factors are now available for some neutron beams under particular circumstances, no systematic study has been performed of the different lung correction methods, for instance as has been done for photon beams (Cunningham, 1982) . Because of lack of adequate information, particularly for the higher energy neutron beams, it is, therefore, too early to give recommendations on which algorithms applied for photon beams would be best suited for neutron beams.
Bone.Values for the elementary composition of human bones are given in ICRP Report 23 (ICRP, 1975) and Woodard and White (1982) . The density of a given healthy adult bone does not vary greatly from one human being to another (Woodard and White, 1982) . The use of published values can, therefore, be recommended. It should be pointed out, however, that the value of 1.85 g cm-3, which is often cited for the densi- ty of bone, is the density of compact bone tissue and not the average density of the skeleton, which would be more relevant for dose calculations. The mineral content, and consequently the density of bone, can vary between about unity and density of compact bone when affected by a tumor or metabolic disease.
Qualitatively it is to be expected that the perturbation in the neutron absorbed dose behind bone, in comparison with that in an homogeneous phantom, should be small because the kerma in bone is about 60% of that in muscle and the mean density of bone is about 1.5 times that of muscle. Thus, the energy deposited per unit volume is about the same. This is confirmed by the lack of contrast between bone and muscle as seen on radiographs using neutrons produced by the d(16) + Be (8) interaction (Bewley et al., 1973) .
Using d + T neutrons, Hover and Krohnholz (1981) observed a decrease of 4.5% in the neutron component of the absorbed dose behind a 5-cm thick piece of bone. Also, Mijnheer et al. (1978b) found that for similar neutrons, the neutron component of the absorbed dose was reduced by 1 to 2% and the photon component increased by 3 to 5% behind a 2.5-cm thick sample of bone-substitute material of greater crosssectional area than the irradiated area in comparison with absorbed doses measured in an homogeneous phantom. Using a similar geometry, with Benelex5 to simulate bone with respect to density but not elemental composition, a similar reduction was observed also with neutrons produced by the d(22) +Be interaction ( Figure 5 .6) but with a thicker sample of Benelex (5.1 cm), the total absorbed dose was reduced by 3 to 4% (Wootton et al., 1977) . For neutrons produced by the d(35) +Be interaction, McGinley and McLaren (1976) found that with samples of bone-substitute material of cross-sectional area smaller than the irradiated field, the total absorbed dose was decreased by 6 to 7% behind 2.3 cm while behind 0.85 and 4.8 cm the reduction was 3 to 5% and 7 to 15%, respectively, depending upon the distance from the bone-tissue interface.
Radiation transport calculations simulating the radiation field from a d(50) +Be neutron therapy unit indicate that behind a 1-cm thick bone inhomogeneity located in a water phantom, the central axis depth doses behind the bone do not differ significantly from those calculated in the absence of bone (Pfister et al., 1981a) .
Except for the data of McGinley and McLaren (1976) , all other data suggest that no correction for the perturbation of the neutron absorbed dose behind 5 Benelex is a trade name for pressed wood manufactured by Masonite Corp. It is manufactured from wood chips and lignin, has a density of 1.43 g cm-3 and a composition of H: 6.5%, C: 48.2%, and 0: 45.3%.
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bone is necessary in clinical practice. However, more experimental data are required for the higher neutron energy beams.
Adipose. The kerma in adipose tissue is about 13 to 16% greater than that in reference tissue (Table 5 .2) and its density is about 0.92 g cm-3.
Measurements (Figure 5 .6) with neutrons produced by the d(22) + Be interaction indicate that behind 4.9 cm or less of fat-substitute material (wax), the reduction in absorbed dose is less than 1 % compared with that in the homogeneous phantom (Wootton et al., 1977) . These data are confirmed by measurements behind a 3-cm thick layer of fat carried out with d + T neutrons (Williams and Mijnheer, 1981) .
Calculation of the kerma within and behind a layer of fat 5-cm thick immersed in a water phantom irradiated with neutrons produced by the d(50) + Be or d(14) +Be interactions shows that the kerma behind the fatty tissue is not significantly different from that in the water phantom in the absence of the fat layer (Pfister et al., 1981a) .
Thus, in clinical practice, no correction is required for the perturbation of the absorbed dose behind fatty tissue.
Geometrical Factors
Alterations in the absorbed-dose distribution due to oblique incidence of the beam, complex curvature of the incident surface or the lack of scattering material may be avoided by the use of tissue-substitute bolus. This is, in fact, a method frequently employed with all energies of neutrons currently in use since a geometrical configuration can be achieved in which attenuation and scattering do not differ significantly from that of the standard phantom. The ideal bolus material would have absorption and scattering properties identical to those of reference tissue, would be easily formed into the required shape (e.g., by molding or machining) and be sufficiently rigid to be convenient in use. However, since it is seldom necessary to use thicknesses of bolus material greater than a few centimeters, the requirement for strict tissue equivalence is frequently relaxed in favor of the practical aspects of preparation and use. Providing the dissimilarity is not too great, particularly with respect to hydrogen content, the resulting errors in the estimation of absorbed doses will be small (see Section 3.1.6).
The presence of tissue-equivalent bolus will provide full secondary charged-particle equilibrium at the skin surface and eliminate skin sparing. This can be avoided by lining the inner surface of the bolus with a nonhydrogenous layer to absorb the recoil-charged particles originating in the bolus. In practice, lead is usually used since, with the thicknesses required, this can be formed readily into the required shape; abo\lt 0.1 mm of the lead is sufficient for neutrons produced by the d(16) + Be(8) interaction (Catterall et al., 1971) and about 1 mm for neutrons produced by the d(49) + Be interaction (Smathers et al., 1980a, b) . For those cases where the tumor invades the skin, the lead can be omitted locally and the full absorbed dose delivered to the skin surface.
For neutron beams incident obliquely on the patient or on a complex curved surface, it is frequently advantageous not to use bolus and to determine the actual absorbed-dose distribution by calculation. These methods are considered in Section 5.2.3.
The reduction in the absorbed dose at the exit surface due to the lack of backscatter is seldom of importance in estimating the absorbed dose to the tumor but may be of consequence where the absorbed dose to the skin at the exit surface is critical, e.g., during the use of parallel opposed pairs of fields. For neutrons produced by the d(16) + Be(8) interaction, correction factors have been measured by which the neutron-absorbed dose under full scatter conditions has to be multiplied to derive the neutron-absorbed dose at the exit surface. Measured values varied from 0.94 to 0.87 for field sizes of 5 cm X 5 cm, and 20 cm X 20 cm, respectively (Catterall and Bewley, 1979) but at distances greater than 4 to 6 cm from the exit surface, the reduction in absorbed dose was negligible. With neutrons produced by the d(22) + Be interaction, the central axis depth dose is independent of phantom size for depths up to 4 cm from the exit surface for a 10 cm X 10-cm field. In comparison with a cubic phantom with sides 45-cm long, the absorbed dose near the exit surface of a 15cm cubic phantom was reduced by 5% (Wootton et al., 1977) .
Using neutrons produced by the p(66) + Be (49) interaction, Awschalom et al. (1982a) found that the removal of backscatter material reduced the exit absorbed dose by 4 to 10%, depending upon the field size, and that a reduction of 2 to 3% still persisted at a proximal distance of 5 cm from the exit surface.
For orthovoltage x rays (HVL 1.5 to 2.5 mm Cu), the correction factors at the exit surface vary from 0.81 for a 25 cm 2 field to 0.66 for a 400 cm 2 field. For cobalt-60 gamma rays and 4-MV x rays, the factor is never less than 0.96 at 5 mm before the exit surface (Meredith and Massey, 1968).
Treatment Planning
A treatment plan in radiation therapy is usually considered to be a representation of the distribution of absorbed dose within the patient resulting from the application of prescribed beams of ionizing radiation. In this section, treatment planning is considered, primarily, to be the execution of those procedures which result in a description of the distribution of absorbed dose throughout the volume of interest within the patient. It must be emphasized, however, that this is only one stage of a continuous process which constitutes the planning and delivery of a course of radiation therapy.
The techniques used for the treatment of tumors with fast neutrons are frequently adaptations of those used with photon therapy. For example, the modification of the basic absorbed-dose distribution in the phantom by the introduction of beam modifying devices such as wedge filters and local shielding is employed as often with neutron therapy as with photon therapy. In some situations, however, particularly where the neutron beam is fixed and horizontal, it has been necessary to develop special techniques for use with neutrons, e.g., for patient immobilization.
The treatment of most tumors with fast neutrons, as with photons, generally requires the combination of two or more beams in order to achieve an acceptable distribution of absorbed dose. Methods used to determine the distribution of absorbed dose within the patient for photon beams are discussed in ICRU Report 24 (ICRU, 1976) . The procedures used with neutrons are similar to those used with photons but there are differences in detail. These result from differences in the energy-absorption processes, the absorption and scattering characteristics of the two types of radiation, and the presence in the neutron beam of a component of absorbed dose due to photons.
The use of radiation-transport calculations to determine, for neutron beams, the distribution of absorbed dose in three dimensions within an heterogeneous phantom have been studied (Bohm et al., 1978; Pfister et al., 1981a; Burger et al., 1981a) . In principle, such calculations can be carried out for any combination or orientation of incident beams and are useful for the fundamental understanding of neutron irradiations under certain circumstances. However, because of the large number of events which have to be followed to obtain acceptable statistical accuracy and the size of the data base required, such purely theoretical approaches are impractical for routine use at the present time.
Usually, the distribution of absorbed dose in the homogeneous standard phantom is measured only in the principal planes of the field, i.e., planes which contain the beam axis and which are parallel to one of the sides of the field. These data may be stored in analogue form as isodose charts, in digital form as a two-dimensional matrix of numbers or represented by a generating function which permits the direct calculation of the absorbed dose at any point within the principal plane. Furthermore, when two or more fields are combined for the treatment of a tumor, generally they have a common principal plane. Thus, it is usual to calculate the distribution of absorbed dose in this common plane. The principal stages of such a calculation are:
(1) Generation of the distribution of absorbed dose within an homogeneous standard phantom for each field with allowance for beam modifying devices, where applicable.
(2) Correction of these distributions for the inhomogeneities and irregularities of the patient.
(3) Summation of the corrected distributions to obtain a composite distribution of absorbed dose within the patient. ( 4) Derivation of isodose curves by interpolation for display and record purposes. The following section, therefore, summarizes the various techniques used within each of the four stages outlined above, with specific reference to the use of digital computers. The use of analogue methods (manual planning) for fast neutron beams differs little from those used with photons. The latter methods have been discussed briefly in ICRU Report 24 (ICRU, 1976) . Status reports on treatment planning at neutron therapy centers have been presented at a Workshop on Treatment Planning for External Beam Therapy with Neutrons (Burger et al., 1981b) .
Single Beam Absorbed-Dose Distributions
The algorithms by which absorbed-dose distributions are calculated are called beam models. Beam models used in photon therapy have been reviewed in ICRU Report 42 (ICRU, 1987) . If an institute is using a particular modeling technique for computerized photon-therapy planning, it is advantageous to that institute to use the same model, suitably adapted, for neutron irradiations. This facilitates not only the handling of the input data but also the combination or comparison of neutron and photon absorbed-dose distributions for the treatment of the same tumor. The models can be divided into three groups: (a) the matrix model, (b) generating functions, and (c) separation of primary and scattered radiation.
The matrix model is the simplest way of representing the absorbed-dose distribution. Absorbed-dose values measured along the beam axis and beam profiles measured at several depths are stored in a data file in the computer. The spatial separation of the sampling points is chosen such that the absorbed dose at any point in the principal plane can be obtained with the required accuracy by linear interpolation. Usually the fan-line system is chosen as the coordinate system, the matrix points being the intersections of "rays" originating from the source center with lines orthogonal to the beam axis. If only a limited number of field sizes are available, the overall amount of data required may not present a serious storage problem. If, however, a large number of collimators are used or an 5.2 Treatment Planning • • • 61 adjustable collimator system is available, it might be necessary to reduce the number of measurements and the amount of data handling. To do this, the data for a limited number of field sizes are stored and interpolation is used for other field sizes. In addition, it is sometimes assumed that the profiles are a function of the field width only and independent of field length. If this assumption is used, it must be checked experimentally for the particular neutron therapy facility.
Generating functions can be used to calculate directly the absorbed dose at any point in the irradiated field though, usually, they are restricted to the principal plane. In general, these functions are the product of two expressions, one representing the beam axis depth-dose or tissue-air ratios (TAR) and the other representing the off-axis ratio (OAR). The functions may be derived in a purely empirical way, e.g., by curve fitting, or by using a projective model. A survey of mathematical approximations of the beam axis depthdose curves and off-axis ratios for photons has been given by Redpath and Wright (1981) . Modifications of these analytical expressions have been applied in a number of neutron treatment-planning computer programs. For example, Rosenberg and Awschalom (1981) fitted the off-axis ratios of the p(66) + Be(49) beam by an algorithm developed by van de Geijn (1972) for external beam photon therapy.
The decrement line method (ICRU, 1976) has been applied in several neutron therapy centers. These lines represent the points where the absorbed dose is a constant fraction of the absorbed dose on the central axis of the beam at the same depth. If it is assumed that straight decrement lines exist which intersect at the center of the neutron-generating target, inaccuracies can be introduced, especially in the penumbra (Vynckier et al., 1981) . However, by using a second projection center for the decrement lines on the beam axis, the agreement between the model and the experimental data can be improved, as demonstrated by Hess et al. (1981) for a beam of neutrons produced by the d + T interaction. The use of multiple projection centers was introduced, originally, by van de Geijn (1972) in his photon treatment-planning model. It should be noted that the decrement line method cannot be applied directly with filtered neutron beams, where off-axis peaking of the beam profiles occurs at shallow depths. For the flattened d(50) +Be beam, the decrement line method has been modified using a semi-empirical model (Hagstrom et al., 1976) .
Another approach is that of Meissner and Rassow (1981) which starts with a pencil beam having both neutron and photon components. The shapes of the lateral profiles of the pencil beams are obtained by Monte Carlo calculations while the actual coefficients are found by fitting calculated beam profiles to measured dose distributions (Meissner, 1982) . The absorbed dose at any point in an irradiated medium is due to primary and scattered radiation for which the spatial distributions differ. The two components can be calculated separately and added at each point. The method is especially useful for the calculation of dose distributions when irregularly shaped fields are used. It has been applied with a d(22) + Be neutron beam (Eenmaa et al., 1981) . In addition, variations in the scatter component due to other causes (e.g., nearby inhomogeneities) can be calculated accurately by this method.
Some examples of single beam absorbed-dose distributions in an homogeneous standard phantom are shown in Figure 5 .8. They show the shortcomings of the lower-energy neutron beams relative to megavoltage photon beams, e.g., the relatively poor penetration, the rounded isodose curves and the relatively wide penumbra, as discussed in Section 4.
In the preceding discussion, no consideration has been given to the combination of the neutron and photon components of the absorbed dose. Treatment plans based on neutron absorbed dose, total absorbed dose, and a weighted sum of the absorbed doses due to each component (e.g., total effective doses 6 ) have all 6 The concept of the total etfectiue dose (or effectiue dose) was introduced by the Hammersmith group with the aim of specifying a neutron dose which could be equivalent to the combination of the actual neutron dose and photon dose (Catterall and Bewley, 1979) . The total effective dose, Dem is defined as the sum of the neutron absorbed dose, Dm and the gamma-ray absorbed dose, D,, divided byR:
The factor 1/R was applied to take into account the differences in RBE between neutrons and gamma rays. A value R = 3 was adopted for the neutron energy used at the Hammersmith cyclotron. The respective merits of the different methods for specifying the absorbed dose in neutron therapy will be discussed in another ICRU Report.
been used in clinical practice. Most of the beam modeling techniques discussed above can be adapted to suit any of these representations.
Separate calculations of the absorbed-dose distributions due to neutrons and photons, respectively, will allow distributions of total absorbed dose or "total effective dose" to be computed easily. In practice, distributions expressed in terms of neutron absorbed dose, total absorbed dose, or total effective dose show only small deviations from one another within the target volume. These isodose distributions, however, can conceal a significant variation of the gamma-ray contribution along an isodose line outside the target volume, a variation which might lead to therapeutically relevant differences in biological response.
For reporting the absorbed dose, the total absorbed dose and the photon contribution are required. Separate neutron and photon dose distributions will provide this information directly at every point. This is particularly important where critical organs are located close to the target volume because the biological response of these organs will depend not only on the total absorbed dose, but also on the proportion of the absorbed dose contributed by the photons. However, in many cases, a distribution of total absorbed dose in combination with a calculation of the photon absorbed dose at representative sites, including the specification point and points within the organs at risk, will also give adequate information.
Modification of Single Beam Absorbed-Dose Distributions
Beam modifying devices are used with fast neutron beams for the same reasons that they are used with photon beams. These are to produce absorbed-dose distributions of specific shape, to protect certain parts of the patient, or to compensate for the modifying effect of the patient contour. Flattening filters, which modify the original rounded open-beam isodose distribution, have been discussed under beam characteristics (see Section 4.5).
The wedge filter is the most frequently used beam modifying device in photon as well as in neutron therapy. The angle through which this tilts the isodose curves at a particular depth on the beam axis relative to its normal position perpendicular to the beam axis is called the wedge angle. This wedge angle is not constant for any given wedge and decreases with increasing depth due to differential beam hardening across the wedge, the presence of scattered radiation, and geometrical effects. Thus, as with photon therapy, a reference depth of 10 cm along the beam axis is recommended for the statement of the wedge isodose angle.
Wedged beams are used frequently to obtain a uni-
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form distribution of absorbed dose in the region of overlap of two beams which are not coaxial, a region which may extend from the surface to a depth of several centimeters (ICRU, 1976) . Wedges are important, therefore, for the treatment of tumors of the head and neck region. In particular, these tumors have been treated quite frequently with fast neutrons due, in part, to restrictions placed on the therapeutic use of many fast neutron beams by their poor penetration. For example, in Edinburgh, where 25% of the treatments have been for tumors in the head and neck region, 30% of all the treatments have required the use of wedged fields (Williams and Mijnheer, 1981) . The modification to the shape of the isodose lines by insertion of a wedge is governed by the shape and material of the wedge and the neutron energy. A wedge angle of 45 ° is most commonly used, but other angles are available in many centers. As with photon beams, it is possible to combine wedged and nonwedged beams in order to reduce the wedge isodose angle. Wedge filters have been constructed from polyethylene, polystyrene, Benelex, or Teflon. Some centers have added boron to these materials to reduce the gamma-ray absorbed dose originating from neutron interactions in the wedge. Even with boron added, the relative gamma-ray absorbed dose at a certain point will be higher for the wedged beam than for the unwedged beam. The increase in the proportion of the total absorbed dose due to gamma rays will be about equal to that observed after a shift to larger depths in the phantom equal to the thickness traveled by the neutrons through the wedge.
Usually, wedge filters in neutron beams are positioned manually at the distal end of the collimator. They can be located either in the collimator, in order to save space between the collimator and patient, or attached externally to the collimator. In the former case, a separate wedge is required for each field size while in the latter case a single wedge suffices for a number of field sizes.
In some modern machines, the wedge filters are positioned close to the target in wedge filter drawers, the appropriate wedge being selected by remote control. In such a situation, space will be at a premium but induced radioactivity should not be critical. Steel may then be the material of choice due to its large attenuation effect (Ten Haken et al., 1982) .
Wedges made from an hydrogenous material should be placed as far as practical from the patient's skin to avoid a reduction in the dose build-up effect in the skin due to recoil protons emanating from the wedge as a result of fast neutron interactions in the wedge. The addition of a thin layer of lead or other high atomic number material to the outer surface of the wedge might also be necessary to eliminate this proton fluence from the wedge.
In megavoltage x-ray therapy, a single wedge often serves for all beam widths. If such a filter is fixed centrally in the beam, it has the disadvantage of reducing the radiation intensity unnecessarily, especially for small beam sizes. In neutron therapy, this can be a serious drawback because of the low dose rate often employed. Alignment of the thin end of the wedge with the edge of the field is used, therefore, in many neutron therapy centers. Even in such a situation, the introduction of a 45° wedge reduces the dose rate by a factor of between 1.3 and 3 depending on the field size and neutron energy.
Some examples of isodose distributions for wedged, fast neutron beams with a 45° wedge angle are given in Figure 5 .9. The area of the region where the absorbed dose exceeds the maximum absorbed dose on the beam axis, usually referred to as a hot spot, and the maximum absorbed dose within this hot spot, increase with decreasing neutron energy. They also increase with increasing width of the beam and with increasing wedge angle. If a wedge filter is constructed with simple triangular dimensions, the isodose lines will deviate from a straight line, especially at larger depth ( Figure 5.9a, b) . The shape of the isodose lines can be optimized in a semi-empirical manner, however, by designing wedges with a more complex surface, as demonstrated in Figure 5 .9c for a d + T beam. The straighter isodose lines in Figure 5 .9c have been obtained at the expense of a larger hot-spot area. The application of wedged beams may give rise, therefore, to regions of absorbed dose higher than that in the target area, especially for the lower neutron energies. However, it can sometimes be arranged for these hot spots to occur in bolus material when this is used to compensate for the irregular surface of the patient.
Beam modeling techniques for wedged beams are generally the same as those used for the unmodified beam. If the matrix model is used, the wedged beam data are entered as a new beam. This is not possible, however, with treatment planning systems that accept only symmetrical beam profiles. The projective method, which is often applied with megavoltage x-ray beam therapy, is also used in a number of centers for the calculation of dose distributions of wedged neutron beams. In this method, the reduction of absorbed dose at any point in the field by insertion of the wedge is accounted for by multiplying the absorbed dose in the situation without the wedge by the wedge attenuation factor T exp(-J'w(/,), where 11-w is the effective linear attenuation coefficient of the wedge material and d is the length of the path that the ray traverses through the wedge. By multiplying the exponential part of the correction factor by the factor T, the output on the central axis can be adjusted to the measured value, in order to take into account the effect of radiation scattered from the wedge into the monitor. Usually a sin-gle value of 11-w can be chosen which gives good agreement between the calculated and measured shapes of the isodose lines if the differential beam hardening across the wedge is small. However, such a simple projective method cannot be applied, if a considerable fraction of the total absorbed dose results from scattering in the collimator. The projective method can be used in combination with the matrix model, analytical functions and methods separating the primary and scattered components of the absorbed dose.
The modification of an absorbed-dose distribution by partially shielding a regular shaped field is more difficult and less perfect for fast neutron beams in comparison with photon beams. This is because optimal shielding of fast neutrons requires a greater thickness of material than generally applied for shielding of photon beams. Also, the contribution to the absorbed dose at any point within the patient due to scattered radiation is higher, especially for the lower energy neutron beams. In addition, for some neutron sources, the source dimensions are large compared with those for some megavoltage x-ray sources. Consequently, the variation of the absorbed dose in the shielded region of the field will be higher than that which can be achieved with external beam photon therapy.
Irregularly shaped fields can be obtained, in practice, by fixing a field-shaping insert inside the collimator or by placing shielding blocks on a tray or table which can be positioned between the collimator and the patient if space permits. Polyethylene, wood, and iron have all been used for the construction of the inserts.
The calculation of the absorbed-dose distributions for irregularly shaped photon beams is discussed in ICRU Report 24 (ICRU, 1976) . Most of these methods are based on scatter-air ratios and, in principle, can be applied to fast neutron beams. In addition, the method of"subtractive isodose charts" described by Sundbom (1965) should also be applicable to neutron beams. In this method, the dose distribution due to a field having the same size and shape as the insert is subtracted from that due to the unshielded beam.
In many cases, the area of the insert is small compared with the field area and the insert is also located in one corner of a rectangular field. Under these circumstances, the effect of the insert on the absorbeddose distribution in the principal plane will be small and may often be neglected. Experimental verification will, however, be necessary.
Combination of Single Beam Absorbed-Dose Distributions and Patient Data
The discussion in Section 5.2.2 was concerned with methods whereby the standard absorbed-dose distributions in an homogeneous phantom can be represent- ed for treatment planning purposes. The present section considers the methods whereby the effects on the absorbed-dose distribution resulting from differences between the patient and the homogeneous phantom can be combined with these. The principal corrections to be considered are:
(1) Modifications to the local kerma due to differences in the elemental composition of the tissue or organ.
(2) Corrections for the effect of the density and elemental composition of a particular organ or tissue on the absorbed dose within, or remote from that organ or tissue. (3) Corrections for the irregular or oblique surface of the patient and the lack of scattering material on the standard isodose distributions.
For treatment planning purposes, many centers ignore the variation of absorbed dose with elemental composition and cite instead the kerma in the reference material. This is analogous to the procedure usually adopted in photon therapy. It should be noted that these variations in kerma between bone or fat relative to soft tissue are often in opposite directions for neutron and photon beams and that judgments based on experience with photons could be misleading. Table 5 .2 shows that fat and bone are the two principal tissues where corrections for differences in elemental composition need to be applied. Since the exact elemental composition of any tissue within a particular patient is unknown, corrections must be made on the basis of average values such as those given in Table  5 .1. For any particular beam, a kerma factor ratio similar to those in Table 5 .2 can be calculated for the relevant tissue and used to correct the absorbed-dose distribution within that tissue, assuming the existence of secondary charged-particle equilibrium. Close to the boundary of the tissue, the calculation of the absorbed dose is difficult due to the lack of secondary charged-particle equilibrium and a region will exist in which the absorbed dose cannot be estimated accurately. However, where this is important clinically, consideration must be given to the possible over-or under-dosage adjacent to such an interface, e.g., the low dose immediately behind a bone surface.
The kerma factor ratios given in Table 5 .2 were calculated using energy spectra measured in air, i.e., in the absence of scattered neutrons from a phantom or patient. In the patient, the energy distribution of the neutrons will differ from that measured in air, but within the beam defined geometrically by the collimators, the variation of kerma factor ratio with position in general will be small (Section 5.1.2). Outside the beam, the energy spectrum will differ significantly from that in the beam since most of the neutrons have been scattered either in the patient or collimator. Consequently, the kerma factor ratios at such points may differ significantly from those within the beam. However, at these points the absorbed dose is small compared with that in the main beam and corrections are relatively unimportant.
The principal regions for which corrections for the effect of density and, to some extent, composition are required are air cavities and lung. ICRU Report 24 (ICRU, 1976) reviews the methods by which corrections for the effect of such inhomogeneities may be estimated for photon beams. These include the Tissue-Air Ratio Method, the Effective Attenuation Method, the Isodose Shift Method, and the Power Law Tissue-Air Ratio Method only for points lying behind an inhomogeneity. The latter method has been generalized by Sontag and Cunningham (1977) to include points within an inhomogeneity. In addition, Sontag and Cunningham (1978) have developed the Equivalent Tissue-Air Ratio Method which takes into account the full three-dimensional structure of the irradiated body for each point of calculation. In a review, Cunningham (1982) has compared these different methods for correcting tissue inhomogeneities for photon beams.
All of the methods used with photon beams should, in principle, be applicable to the fast neutron component of the absorbed dose from fast neutron beams. However, it would appear that the methods which separate the primary and scattered components of the absorbed dose might give greater accuracy because of the relatively high contribution of scattered radiation to the absorbed dose at any point compared with megavoltage photon beams. [For example, the backscatter factor for a 20 cm X 20-cm field is 1.20 for fast neutrons generated by the d(22) + Be interaction compared with 1.07 for cobalt-60 gamma radiation (Weaver et al., 1979a) .] For the component of the absorbed dose due to gamma rays, such methods may not be applicable since a significant proportion of the gamma rays is produced by interactions of the neutrons within the body of the patient. However, the absorbed dose due to photons is usually less than that due to fast neutrons by a factor of 5 to 20, depending upon depth and field size, and the overall errors introduced by omitting corrections to the photon absorbed dose will be small.
For air cavities, the isodose shift method can be used with factors similar to those used with photon beams which have comparable penetration into tissue (Section 5.1.4). The effective attenuation method has been used by Hover et al. (1981) for both air cavities and lung. However, it was found that this method overestimates the dose behind the lung. The error depends upon the distance from the lung and to allow for this, a distance correction factor has been introduced.
For neutrons produced by the d(15) + Be interaction, a method based on the equivalent depth has been used for lung (Williams and Mijnheer, 1981) . In this method, the equivalent depth is calculated from the actual depth by means of the density of the inhomogeneity and the distance through it. An inverse squarelaw correction is then applied to correct for the eff ective change in distance from the target. Corrections for d(50) +Be neutrons based on this method were compared with those obtained from the formula derived by Smith et al. (1976) from in vivo measurements in rhesus monkeys (Section 5.1.4). The agreement was poor, but would have been improved by the use of position correction factors as described in ICRU Report 24 (ICRU, 1976) for the effective attenuation method.
The techniques discussed above for determining the effects resulting from the presence of an inhomogeneity assume that the inhomogeneity lies on a direct path between the source and the point of interest. If the inhomogeneity lies adjacent to the direct path, only the scattered radiation reaching the point will be modified, the direct radiation remains unaltered. Weaver et al. (1979a) have discussed a method based on measurements of scattered radiation from hydrogenous samples in air for correcting for such inhomogeneities. Good agreement was obtained between the calculated and measured absorbed doses in a phantom, particularly for structures located at shallow depths.
Corrections for missing or excess tissue can be eliminated if bolus is used as discussed in Section 5.1.4. When bolus is not used, computational techniques are required to obtain the distribution of absorbed dose in an homogeneous medium even if wedge filters are used to compensate for the obliquity of the surface. These calculations can be carried out either by the isodose shift method, the effective SSD method, the modified SSD method as introduced by Milan and Bentley (1974), or the tissue-air ratio (TAR) method. Rassow and Hensley (1981) have compared the tissue-air ratio method, the effective SSD method, and the isodose shift method for neutrons produced by the d(14) + Be interaction. For computerized treatment planning, the tissue-air ratio method was the most advantageous. Typical differences between calculated and measured absorbed-dose distributions of less than ±3% of the local absorbed dose corresponding to ±2.5 mm between calculated and measured isodose lines in the center of the beam and ±6% or ±5 mm near the edge of the field. The effective SSD method was only slightly less accurate. With a beam produced by the d(15) + Be reaction, ratios of measured absorbed doses to absorbed doses calculated using the modified effective SSD method varying between 0.99 and 1.05 have been reported (Williams and Mijnheer, 1981) . These data suggest that the latter method of correc- For manual planning, the isodose shift method is the most convenient method to use. Rassow and Hensley (1981) recommend that for neutrons produced by the d(14) +Be interaction, a shift of the isodose lines by a factor 0.8 times the thickness of missing or excess tissue is applicable, giving deviations equal to those obtained with the TAR method. For the neutron beam produced by the d(16) + Be(8) reaction, an isodose shift factor of 1.0 has been suggested (Catterall and Bewley, 1979) , whilewithad(50) +Be beam, Vynckier et al. (1981) found a value of 0.8 ± 0.03. The shift factor of 0.8 corresponds to that given in ICRU Report 24 (ICRU, 1976 ) for x rays with accelerating voltages in the range 150 kV to 1 MV.
In the absence of additional data, a factor of 0.8 is recommended for all beams, but this should be confirmed experimentally.
Combination of Single Beams
The treatment of most tumors requires a combination of two or more beams in order to achieve an acceptable distribution of absorbed dose in the target volume and elsewhere. Clinical factors which influence the position and size of the treatment beams include the site, size, and shape of the target volume, and the proximity, size, and shape of organs at risk. The treatment technique employed for the irradiation of a specific tumor may be different, however, if fast neutrons are used instead of photons. This results from differences in the physical properties of the two types of radiation and the technical specifications of the treatment units. A discussion of the impact of these considerations has been given by Duncan et al. (1981) .
The physical properties of the beam which influence treatment planning are: quality, penetration, penumbra, and flatness. Quality has been discussed in Section 2 and will not be considered further here. Figure  5 .10 illustrates the physical differences between various neutron and photon beams by comparing the absorbed-dose distributions in an homogeneous medium for two parallel opposed 10 cm X 10-cm fields separated by 14 cm. For the two low-energy neutron beams, the skin dose is greater than for the high energy beams and the absorbed-dose distribution in the central region is less uniform. The narrowing of the high dose region which occurs with the low energy beams might result in the use of field sizes which are about 1 cm larger than those used with high-energy fast neutrons or megavoltage photons.
Duncan et al. (1981) have pointed out that, as a result of the above considerations, treatments with fast neutrons often necessitate the use of more treatment fields with greater hot spots than a comparable treatment with photons. This is illustrated in Figure  5 .11 which compares plans for the treatment of the same bladder tumor prepared by various neutron therapy centers (Mijnheer et al., 1985) . The treatment plans using the high-energy neutron beams (whether neutrons alone or in combination with photons) differed little from those obtained with photons at most of the centers. However, in order to achieve a reasonable distribution of absorbed dose in the target volume with the lower energy beams, six fields were usually used.
For the treatment of a carcinoma of the floor of the mouth or a carcinoma of the base of the tongue, Mijnheer et al. (1985) found that most centers used very similar techniques with neutrons and photons. However, even for some tumors of the head and neck, clinical considerations dictate the use of more treatment fields with fast neutrons than with photons. For example, Figure 5 .12 compares a neutron treatment plan using d(16) + Be(8) neutrons for the treatment of a tumor of the maxillary sinus which extended over the midline, with a plan for the same treatment using 6.5-MV x rays. In order to achieve reasonable uniformity of absorbed dose through the target volume and an acceptable absorbed dose to the unaffected eye with the neutrons, it was necessary to use a bolus mask, three fields, and two different wedges. The greater penetration of the x-ray beam resulted in a considerably simpler plan.
At the present time, neutron therapy machines which possess all the technical facilities associated with, and considered essential for, megavoltage x-ray machines are being installed or have just been put in operation. The most important of these features for treatment planning are the angular range of gantry rotation, the ability to undertake rotation or arc therapy, the distance between the end of the collimator and the isocenter, and the continuous adjustment of the collimators.
The range of movement of the treatment head influences significantly the selection of treatment fields and the techniques that may be applied in clinical practice. Some present neutron therapy machines have limitations of movement compared with megavoltage x-ray machines, while others have no movement at all, the beam being fixed horizontally or vertically. Where the movement of the beam is limited, the six-field treatment shown in Figure 5 .11 can only be carried out by turning over the patient. For this, the patient has to be planned on the simulator in both positions to allow for possible movement of the target volume.
Duncan et al. (1981) consider that rotation or moving arc therapy could be an advantage if the range of movement is great enough. Where the range of movement is limited, there is no advantage in terms of lower incident skin dose or improved definition of the treatment volume compared with the six-field technique.
With a beam which is fixed in direction, the treatment techniques are frequently restricted because of the necessity to position the patient correctly relative to the beam as opposed to directing the beam to suit the position of the patient. Thus, although most patients are placed in the supine position for treatment with an adjustable beam, the patients are frequently placed in the vertical position (sitting, kneeling, or standing) when horizontal beams are used. This can 5.2 Treatment Planning •.• 69 NEUTRONS Fig. 5.11 . Fast neutron treatment plans for a carcinoma of the bladder (dotted area) prepared by various neutron therapy centers. The 90, 50, and 20% isodose lines are indicated by solid, dashed, and dotted lines, respectively. The symbol • in 7 and 9 indicates an additional photon beam. l, 7, 9 were considered to be high-energy neutron beams. A double arrow means that two beams of the same type of radiation but different field size have been employed. Also indicated in the figure is the relative absorbed dose at the rectum (Mijnheer et al., 1985) . make difficult the immobilization of the patient in a comfortable position and might result in the use of a less than ideal treatment technique.
With some machines, the conflicting requirements of an adequate absorbed-dose rate at the isocenter and the provision of effective collimation restricts the distance between the end of the collimator and the isocenter. This can place constraints on the application of certain treatment techniques such as the use of partial shielding and rotational or arc therapy.
At the present time, interchangeable inserts are used for collimation with nearly all neutron therapy machines. This restricts the number of field sizes which are available and could result in the use of a field size which is not ideal. In addition, some of the inserts are too heavy to be handled manually and require special handling equipment. It is, therefore, difficult to undertake a treatment which requires more than one field size. The use of a continuously variable collimation system will, therefore, add to the flexibility of treatment planning. Such a system has been developed for the neutron beam produced by the d(16) + Be(8) interaction (Bewley et al., 1981) . A continuously variable multileaf collimator has been described in Section 4.6.
Future Developments
The use of whole body computed tomography (CT) for photon and electron treatment planning purposes is increasing rapidly. For charged particle therapy, CT information is used for the construction of all treatment plans (Chen et al., 1979; Pedroni, 1981; Goitein et al., 1982) . In addition to being used to define the position of the treatment volume relative to organs at risk, CT data can be used quantitatively to calculate absorbed-dose distributions, especially in or near inhomogeneities. A number of groups are developing programs for this purpose for photon or electron treatment planning. These programs include, as a first step, the conversion of CT values into electron densities. However, for neutrons as well as for charged particles, it is not the electron density which determines the energy deposition but the type and density of the nuclei. This problem has been solved for charged particle therapy by converting the CT values of each pixel into a water-equivalent pathlength (Chen et al., 1979) . For neutron therapy planning, a similar use of CT data has been reported (Hover et al., 1981) . Computerized tomography using nuclear magnetic resonance (NMR) may be helpful in providing tomographic information as well as quantification of the hydrogen content of various normal and malignant tissues in situ.
Due to changing body contours and the outline of inhomogeneities, the dose distribution in other planes may deviate significantly from that in the principal plane. Real three-dimensional planning, which has to be distinguished from coplanar planning using principal plane absorbed-dose distributions and CT information of other slices, is now being developed for photon treatments and may be modified for neutron therapy planning. In addition to the calculation of threedimensional dose distributions, the application of three-dimensional display systems is a rapidly expanding field. Three-dimensional perspectives of the internal anatomy as well as the presentation of threedimensional dose distributions projected on these anatomical structures, are under development (e.g., see Bloch and Goodman, 1981; Goitein et al., 1983) .
